相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease
Oliver Bracko et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)
Enhanced Hemodynamic and Clinical Response to αCGRP in Migraine Patients-A TCD Study
Darja Visocnik et al.
FRONTIERS IN NEUROLOGY (2021)
Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice
Dayalan Sampath et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease
Nils Korte et al.
ACTA NEUROPATHOLOGICA (2020)
Design and Development of a Behaviorally Active Recombinant Neurotrophic Factor
Nicholas J. Pekas et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Carbamoylated erythropoietin induces a neurotrophic gene profile in neuronal cells
Neeraj K. Tiwari et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Carbamoylated erythropoietin modulates cognitive outcomes of social defeat and differentially regulates gene expression in the dorsal and ventral hippocampus
Monica Sathyanesan et al.
TRANSLATIONAL PSYCHIATRY (2018)
Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons
Jing Ding et al.
MOLECULAR NEUROBIOLOGY (2017)
Cerebral blood flow changes in remitted early- and late-onset depression patients
Wenxiang Liao et al.
ONCOTARGET (2017)
Erythropoietin regulates POMC expression via STAT3 and potentiates leptin response
Soumyadeep Dey et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Modulation of cellular stress response via the erythropoietin/CD131 heteroreceptor complex in mouse mesenchymal-derived cells
Stefan Bohr et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
VEGFA Activates Erythropoietin Receptor and Enhances VEGFR2-Mediated Pathological Angiogenesis
Zhihong Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
Kamilla W. Miskowiak et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Distinct roles of HIF1A in endothelial adaptations to physiological and ambient oxygen
Yi-Zhou Jiang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
Kamilla W. Miskowiak et al.
NEUROPSYCHOPHARMACOLOGY (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study
Maria Letizia Trincavelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Bridging animal and human models of exercise-induced brain plasticity
Michelle W. Voss et al.
TRENDS IN COGNITIVE SCIENCES (2013)
G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide
M. J. P. M. T. Meens et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cerebral blood flow in Alzheimer's disease
Alex E. Roher et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2012)
Primary Cerebral Blood Flow Deficiency and Alzheimer's Disease: Shadows and Lights
Marianna Mazza et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI
Amy Pinkham et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients
Kamilla W. Miskowiak et al.
PSYCHOPHARMACOLOGY (2010)
ERYTHROPOIETIN ENHANCES OXYGENATION IN CRITICALLY PERFUSED TISSUE THROUGH MODULATION OF NITRIC OXIDE SYNTHASE
Claudio Contaldo et al.
SHOCK (2009)
Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury
Ryoichi Imamura et al.
CELL TRANSPLANTATION (2008)
Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury
Chiara Adembri et al.
CRITICAL CARE MEDICINE (2008)
Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action
Kamilla Miskowiak et al.
BIOLOGICAL PSYCHIATRY (2007)
Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice
Ying Li et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Protective effect of erythropoietin and its carbamylated derivative in experimental cisplatin peripheral neurotoxicity
R Bianchi et al.
CLINICAL CANCER RESEARCH (2006)
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury
F Fiordaliso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
ZH Wu et al.
NATURE MEDICINE (2005)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart
T Osugi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF
D Valdembri et al.
FASEB JOURNAL (2001)
Nerve growth factor signaling, neuroprotection, and neural repair
MV Sofroniew et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes
M Funamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
